Challenges and Opportunities in the Development of Aptamers for TNFα.

about

Challenges and Opportunities in the Development of Aptamers for TNFα.

Item

http://www.wikidata.org/entity/Q38293540

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Challenges and Opportunities in the Development of Aptamers for TNFα.

@en

type

Item

label

Challenges and Opportunities in the Development of Aptamers for TNFα.

@en

prefLabel

Challenges and Opportunities in the Development of Aptamers for TNFα.

@en

P1476

Challenges and Opportunities in the Development of Aptamers for TNFα.

@en

P2093

Bettina Appel

http://www.w3.org/2001/XMLSchema#string

Claudia Nübel

http://www.w3.org/2001/XMLSchema#string

Gabriele Nelles

http://www.w3.org/2001/XMLSchema#string

Ingeborg Hospach

http://www.w3.org/2001/XMLSchema#string

Lothar Petruschka

http://www.w3.org/2001/XMLSchema#string

Michaela Mai

http://www.w3.org/2001/XMLSchema#string

Nadejda Krasteva

http://www.w3.org/2001/XMLSchema#string

P2860

Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels

In vitro selection of DNA aptamers binding ethanolamine.

Selection of aptamers for molecular recognition and characterization of cancer cells.

Adsorption and viscoelastic properties of fractionated mucin (BSM) and bovine serum albumin (BSA) studied with quartz crystal microbalance (QCM-D).

Arsenic removal from Vietnamese groundwater using the arsenic-binding DNA aptamer.

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.

Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha.

Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

P2888

s12010-016-2002-2

P304

398-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12010-016-2002-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Sabine Müller

P577

2016-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010139026

http://www.w3.org/2001/XMLSchema#string

P698

26922730

http://www.w3.org/2001/XMLSchema#string